OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
32
Results
Show all
Save search
Copy query
Show results for
Unknown
(32)
Publication Date
Release Date
2018
(29)
2021
(1)
2014
(1)
2013
(1)
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma.
Not available
S-EPMC4021043
|
biostudies-literature
Cite
lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer.
Not available
S-EPMC6143179
|
biostudies-literature
Cite
Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease.
Not available
S-EPMC9908069
|
biostudies-literature
Cite
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.
Not available
S-EPMC5957518
|
biostudies-literature
Cite
Comprehensive Characterization of Cancer Driver Genes and Mutations.
Not available
S-EPMC6029450
|
biostudies-literature
Cite
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.
Not available
S-EPMC6075733
|
biostudies-literature
Cite
Systematic Analysis of Splice-Site-Creating Mutations in Cancer.
Not available
S-EPMC6055527
|
biostudies-literature
Cite
Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types.
Not available
S-EPMC5933844
|
biostudies-literature
Cite
Driver Fusions and Their Implications in the Development and Treatment of Human Cancers.
Not available
S-EPMC5916809
|
biostudies-literature
Cite
Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas.
Not available
S-EPMC5966039
|
biostudies-literature
Cite
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets